Navigation Links
Wilson Center awarded European Union grant for synthetic biology work
Date:11/18/2013

WASHINGTONThe Synthetic Biology Project at the Woodrow Wilson International Center for Scholars has been awarded a grant to participate in SYNENERGENE, a newly launched consortium of 28 groups supported with 4 million ($5.3 million) from the European Commission's Seventh Framework Programme to engage in the responsible governance of synthetic biology.

The Synthetic Biology Project is the only U.S. partner in the SYNENERGENE consortium. Over the next four years, the project seeks to foster responsible governance of synthetic biology by initiating mutual learning processes among a wide variety of stakeholders from science, industry, civil society, policy, education and art.

"The core value of SYNENERGENE is its emphasis on mutual learning between participants," says Eleonore Pauwels, a researcher with the Synthetic Biology Project. "Mutual learning requires the creation of a 'trading zone,' where knowledge can be shared, but no single voice dominates the dialogue and attention is given to expertise."

The Synthetic Biology Project will begin its work with a report identifying synergies between European and international synthetic biology actors around responsible research and innovation. The initiative will also support collaboration and open forums to promote a growing international community of practice focused on the policy aspects and governance of synthetic biology.

The overall initiative is being coordinated by the Karlsruhe Institute of Technology (KIT) in Germany. "Synthetic biology is an emerging field of science and technology, the contours of which are not yet clear," says Christopher Coenen of KIT's Institute for Technology Assessment and Systems Analysis. "We aim to involve citizens and a wide variety of stakeholders at an early stage in the process and to stimulate discussions between them."

Organizers hope the iterative mutual learning process within SYNENERGENE will contribute to a better understanding of synthetic biology research and innovation and enhance public engagement. Activities will be structured by four platforms highlighting synthetic biology's future, as well as its public, cultural and technological perspectives.


'/>"/>

Contact: Eleonore Pauwels
eleonore.pauwels@wilsoncenter.org
202-691-4359
Woodrow Wilson International Center for Scholars/Science and Technology Innovation Program

Christopher Coenen
contact@synenergene.eu
49-721-608-24559
Karlsruhe Institute


Source:Eurekalert

Related biology news :

1. MIT and Wilson Center receive NSF grant to develop synthetic biology research agenda
2. Wake Forest Baptist Medical Center and Cornerstone Health Care Join in Unique Affiliation
3. NIH grant funds multi-center study of mysterious trauma-induced hemorrhaging
4. Cancer imaging centers get £35 million boost
5. Johns Hopkins And Belgian research center to expand health care applications for silicon nanotech
6. Vinyl flooring linked to potentially harmful substances at schools and daycare centers
7. Washington Eye Center is now Precision Eye Care
8. Medbox Partners with Licensed Medical Cannabis Laboratory and Cultivation Center in Canada
9. Family Resiliency Center helps study how food-bank clients afford basic non-food items
10. New York Genome Center announces the New York Stem Cell Foundation as an Associate Member
11. RIKEN and leading Indian institutions launch Joint Research Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... MINNETONKA, Minn. , Jan. 20, 2016   ... that supports the entire spectrum of clinical research, is ... in 2015. MedNet,s significant achievements are the result of ... of) iMedNet eClinical , it,s comprehensive, ... --> --> Key MedNet growth ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/8/2016)... and MANCHESTER, United Kingdom , ... a developer of innovative sensor-based diagnostic products, today announced the ... by new and existing investors.  Proceeds from the financing will ... Scanner , a hand-held device for detecting early-stage pressure ulcers. ... Ireland after receiving CE Mark approval. The ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... 3, 2016  With the growing need for ... is underway, therapies such as monoclonal antibodies, recombinant ... host of indications are in high demand. Conventionally ... development and production of these therapeutics. However, due ... high costs, novel approaches and novel expression systems ...
(Date:2/3/2016)... ... February 03, 2016 , ... Aerocom, a world-leading supplier of ... North American healthcare market. , Aerocom Healthcare, LLC will be based in Denver, ... provide new pneumatic tube systems or expand existing systems within the U.S. and ...
Breaking Biology Technology: